Static Chart Cara Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:08:05 2024-05-13 pm EDT			5-day change	1st Jan Change
0.73 ^USD	+2.01%		-7.59%	-1.75%

Mar. 22	Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024	CI
Mar. 06	Canaccord Genuity Adjusts Cara Therapeutics Price Target to $10 From $11, Maintains Buy Rating	MT

Duration

Period